Postoperative Stenting After Flexible Ureteroscopy in Children With Upper Urinary Tract Stones

November 10, 2026 updated by: Abdelrhman Mansour Ali Ali Elbarbary, Misr University for Science and Technology

Evaluation of the Need for Post-Operative Stenting After Flexible Ureteroscopy Using a Navigable Suction Ureteral Access Sheath in School-Age Children With Medium Sized Upper Urinary Tract Stones

This study aims to evaluate whether postoperative double-J ureteral stent placement can be safely avoided in children undergoing flexible ureteroscopy using a flexible and navigable suction ureteral access sheath (FANS-UAS) for upper urinary tract stones.

The study will include 50 children aged 6-16 years with upper urinary tract stones measuring 1-2 cm who undergo flexible ureteroscopy at Ain Shams University Hospitals.

During the procedure, a suction-assisted ureteral access sheath will be used to facilitate stone fragmentation and removal. The decision to place a postoperative ureteral stent will be based on intraoperative findings and the surgeon's assessment.

The study will assess the need for postoperative stenting, stone clearance, postoperative pain, fever, and other procedure-related complications to determine whether flexible and navigable suction ureteral access sheath (FANS-UAS) can reduce unnecessary stent placement while maintaining procedural safety and effectiveness.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Cairo Governorate
      • Cairo, Cairo Governorate, Egypt, 11511
        • Ain Shams University Hospitals
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

6 years to 16 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patients aged 6 to 16 years of either sex.
  • Patients with upper urinary tract stones measuring 1-2 cm.

Exclusion Criteria:

  • Patients with untreated or active urinary tract infection (UTI).
  • Patients with urinary tract stricture or pelvi-ureteric junction obstruction (PUJO).
  • Patients with renal stones located in a calyceal diverticulum.
  • Patients with a solitary kidney.
  • Patients unfit for anesthesia.
  • Patients in whom insertion of the navigable suction ureteral access sheath is unsuccessful.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: FANS-UAS-Assisted Flexible Ureteroscopy

All participants will undergo retrograde intrarenal surgery (RIRS) using flexible ureteroscopy assisted by a flexible and navigable suction ureteral access sheath (FANS-UAS) for the treatment of upper urinary tract stones. Laser lithotripsy will be performed using a holmium:YAG laser, with suction-assisted evacuation of stone fragments. The decision to place a postoperative double-J ureteral stent will be based on intraoperative findings, including residual stones, ureteral wall injury, bleeding, operative time, and surgeon discretion. Participants will undergo postoperative follow-up for one month.

A 9.5 Fr suction ureteral access sheath (ClearPetra) will be inserted into the ureter during retrograde intrarenal surgery (RIRS). The sheath tip will be positioned in the renal pelvis or calyces near the stone and connected to a suction device. Negative pressure will be adjusted intraoperatively to facilitate irrigation fluid drainage, maintain visualization, and evacuate stone fragments during holmium:YAG laser lithotripsy. The procedure will be performed using a 7.5 Fr flexible ureteroscope.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Successful Avoidance of Postoperative Double-J Ureteral Stenting
Time Frame: Up to 1 month after surgery

Proportion of patients in whom postoperative double-J ureteral stent placement is avoided following flexible ureteroscopy using FANS-UAS without requiring an additional postoperative intervention during follow-up.

Up to 1 month after surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Stone-Free Rate Following Flexible Ureteroscopy
Time Frame: Up to 1 month after surgery

Proportion of patients without residual stone fragments larger than 4 mm, assessed using kidney, ureter, and bladder (KUB) radiography and non-contrast computed tomography of the urinary tract (NCCTUT).

Up to 1 month after surgery
Postoperative Pain Score
Time Frame: Up to 1 month after surgery

Postoperative pain severity assessed using a visual analogue scale (VAS) ranging from 1 to 10, with higher scores indicating greater pain intensity.

Up to 1 month after surgery
Incidence of Postoperative Fever
Time Frame: Up to 1 month after surgery

Proportion of patients experiencing postoperative fever following FANS-UAS-assisted flexible ureteroscopy.

Up to 1 month after surgery
Operative Time
Time Frame: During surgery

Duration of the surgical procedure, measured in minutes.

During surgery
Incidence of Ureteric Stricture
Time Frame: Up to 1 month after surgery

Proportion of patients diagnosed with ureteric stricture during postoperative follow-up.

Up to 1 month after surgery
Incidence of Calyceal Rupture
Time Frame: During surgery

Proportion of patients experiencing calyceal rupture during the surgical procedure.

During surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 30, 2026

Primary Completion (Estimated)

May 30, 2027

Study Completion (Estimated)

May 30, 2027

Study Registration Dates

First Submitted

November 10, 2026

First Submitted That Met QC Criteria

November 10, 2026

First Posted (Actual)

November 16, 2026

Study Record Updates

Last Update Posted (Actual)

November 16, 2026

Last Update Submitted That Met QC Criteria

November 10, 2026

Last Verified

November 1, 2026

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe